Literature DB >> 17069848

Reperfusion injury: does it exist?

Garrett J Gross1, John A Auchampach.   

Abstract

It is well established that reperfusion of the heart is the optimal method of salvaging previously ischemic myocardium. However, the idea of reperfusion injury, i.e. injury caused by the process of reperfusion per se, still remains a controversial issue. In this review, we present mounting evidence supporting the concept that reperfusion injury exists, based on work conducted with adenosine and opioid receptor ligands, and the discovery of two new concepts regarding reperfusion injury: 'postconditioning' (POC) and the reperfusion injury salvage kinase (RISK) signaling pathway.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17069848      PMCID： PMC1876792          DOI： 10.1016/j.yjmcc.2006.09.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


  47 in total

1.  Ligand triggers of classical preconditioning and postconditioning.

Authors:  Eric R Gross; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2006-01-31       Impact factor: 10.787

Review 2.  Myocardial protection in reperfusion with postconditioning.

Authors:  Jakob Vinten-Johansen; Zhi-Qing Zhao; Rong Jiang; Amanda J Zatta
Journal:  Expert Rev Cardiovasc Ther       Date:  2005-11

3.  Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.

Authors:  M B Forman; J V Vitola; C E Velasco; J J Murray; R K Dubey; E K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

4.  Postconditioning the human heart.

Authors:  Patrick Staat; Gilles Rioufol; Christophe Piot; Yves Cottin; Thien Tri Cung; Isabelle L'Huillier; Jean-François Aupetit; Eric Bonnefoy; Gérard Finet; Xavier André-Fouët; Michel Ovize
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

5.  Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway.

Authors:  Eric R Gross; Jason N Peart; Anna K Hsu; John A Auchampach; Garrett J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-14       Impact factor: 4.733

Review 6.  Broad-spectrum cardioprotection with adenosine.

Authors:  J Vinten-Johansen; V H Thourani; R S Ronson; J E Jordan; Z Q Zhao; M Nakamura; D Velez; R A Guyton
Journal:  Ann Thorac Surg       Date:  1999-11       Impact factor: 4.330

Review 7.  Opioid-induced preconditioning: recent advances and future perspectives.

Authors:  Jason N Peart; Eric R Gross; Garrett J Gross
Journal:  Vascul Pharmacol       Date:  2005-03-17       Impact factor: 5.773

8.  A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

Authors:  Allan M Ross; Raymond J Gibbons; Gregg W Stone; Robert A Kloner; R Wayne Alexander
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

9.  Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.

Authors:  Hajime Kin; Amanda J Zatta; Mark T Lofye; Bradley S Amerson; Michael E Halkos; Faraz Kerendi; Zhi-Qing Zhao; Robert A Guyton; John P Headrick; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

10.  Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study.

Authors:  Warren K Laskey
Journal:  Catheter Cardiovasc Interv       Date:  2005-07       Impact factor: 2.692
View more
  31 in total

1.  Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells.

Authors:  D Lin; G Li; Z Zuo
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK.

Authors:  Hu Xu; Yongwei Yao; Zhaoliang Su; Yunbo Yang; Raymond Kao; Claudio M Martin; Tao Rui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-24       Impact factor: 4.733

Review 3.  Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection.

Authors:  Giovanna Lippe; Elena Bisetto; Marina Comelli; Stefania Contessi; Francesca Di Pancrazio; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 4.  Mitochondria from anoxia-tolerant animals reveal common strategies to survive without oxygen.

Authors:  Gina L J Galli; Jeffrey G Richards
Journal:  J Comp Physiol B       Date:  2014-02-07       Impact factor: 2.200

5.  Protective effects of embelin on myocardial ischemia-reperfusion injury following cardiac arrest in a rabbit model.

Authors:  Zhi-Gang Zhao; Zhong-Zhi Tang; Wen-Kai Zhang; Jian-Guo Li
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 6.  Potential Implications of Blood Flow Restriction Exercise on Vascular Health: A Brief Review.

Authors:  Dahan da Cunha Nascimento; Brad J Schoenfeld; Jonato Prestes
Journal:  Sports Med       Date:  2020-01       Impact factor: 11.136

7.  Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Linda L Ye; Li-lu Marie Duan; Li-hui Liu; Zhi-dong Ge; John A Auchampach; Garrett J Gross; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

8.  Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Zhi-Dong Ge; Danijel Pravdic; Martin Bienengraeber; Phillip F Pratt; John A Auchampach; Garrett J Gross; Judy R Kersten; David C Warltier
Journal:  Anesthesiology       Date:  2010-01       Impact factor: 7.892

9.  Blockade of electron transport during ischemia preserves bcl-2 and inhibits opening of the mitochondrial permeability transition pore.

Authors:  Qun Chen; Edward J Lesnefsky
Journal:  FEBS Lett       Date:  2011-02-25       Impact factor: 4.124

10.  MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury.

Authors:  Xiaohong Wang; Xiaowei Zhang; Xiao-Ping Ren; Jing Chen; Hongzhu Liu; Junqi Yang; Mario Medvedovic; Zhuowei Hu; Guo-Chang Fan
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.